Compounding of this drug is currently illegal under federal law in the U.S. However, buzz around the drug’s effectiveness has ...

Non-FDA approved retatrutide is readily available to US consumers from multiple sources, leaving many clinicians grappling with how to manage patients taking the drug.

Megan Hancocks bought a drug labelled as the peptide compound retatrutide in cash from a beautician. Within a week of her ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

Eli Lilly and Company has launched a Phase 3b trial titled “A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 ...

Doctors warn of an "enormous" risk of overdose after testing of a popular unapproved weight loss peptide reveals the product ...

What is Retatrutide? Searches boom over 1,200% for experimental peptide - and should we be concerned?

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.